
Asian American Center cancels annual health fair due to federal funding uncertainty
'Unfortunately, with the current landscape and uncertainty of funding from federal programs, it seems the prudent thing is to postpone the health fair this year,' Elizabeth Chung, the organization's executive director, wrote in an online announcement.
'We have given this careful consideration and weighed various options. We have hesitantly reached this decision after much discussion.'
AACF spokesperson Mark Kraham said more than 1,200 people attended the 2024 health fair, and 725 people received some sort of health service. There were 73 vendors and 360 volunteers.
The AACF is a nonprofit focused on helping immigrants and people from minority communities overcome obstacles to success.
For the last 17 years, the organization, in partnership with Frederick Health, has hosted the Frederick Community Health Fair, bringing together medical service providers, resource agencies, community health workers and language interpreters.
At the fair, people can receive services such as health screenings and exams at no cost. No insurance, proof of residence or appointment is required to attend.
Some of the medical services offered at the fair were blood-pressure screenings, consultations with primary care providers, vaccinations, education on different types of cancers, glucose and cholesterol screenings, and other service referrals.
In her online announcement of the cancellation, Chung said the services at the health fair 'would cost an individual an estimated $1,000 if they had to pay for them.'
Chung said in an interview on March 14 that the health fair is something people look forward to. When they go, they can see how many service providers are there to care for their health.
'They know that we have people that look like them, speak like them, and help them to get this information,' she said. 'So it's not just a screening event. It's already something that they long for like, 'Oh, it's good. At least now, I got information.''
Chung said it's hard to articulate how much money is needed to host the fair, since it's a huge collective effort by the AACF and all of the vendors and agencies that participate.
Each participating organization is putting in its own funds to be part of the event — and right now, many are impacted by interruptions and uncertainty regarding federal funds.
The Trump administration has ordered the federal government to freeze spending, a decision that multiple federal judges have blocked and is shaking up organizations across the nation.
Chung estimated that this year's health fair was going to have nearly 100 organizations participating.
She said it'd be one thing if only some organizations were unsure if they could participate, but the fate of the fair was in flux because many organizations' funding is being affected.
Because of that, the organizations don't know if they'll have the resources to provide services, workers and volunteers to be part of the fair.
Chung said the U.S. Public Health Service Commissioned Corps, which had been participating in the fair for at least five years, was one of the first organizations that confirmed it couldn't be part of this year's health fair.
It would set up a MASH unit — MASH stands for Mobile Army Surgical Hospital — at the fair, which included beds, a consultation area and a blood drawing station.
The Commissioned Corps did not respond to requests for comment made between March 17 and 20 regarding its participation in the fair and why it pulled out of the event.
The AACF might try to host other health events that are smaller but can still help people who would usually attend the health fair.
Heather Kirby, Frederick Health's vice president of integrated care and chief population health officer, said in a statement Monday that the health fair being canceled 'will create a barrier to care for some individuals in our community.'
'Working with our trusted community partners to keep our community healthy remains a top priority of Frederick Health,' she said. 'We will continue to examine ways to collaborate and improve healthcare access to our community.'
The majority of the AACF's funding, 94%, is federal and state grants. The nonprofit has about 40 staff members and has hundreds of volunteers.
Chung said every one of the organization's programs — like family support services, language and financial literacy classes, and workforce development — could be reduced or eliminated depending on access to federal funds.
But the AACF is taking each day as it comes and will continue striving to provide services and help people despite financial uncertainty, she said.
She said right now is the time for lawmakers to look at how nonprofits can leverage each other's resources, stretch any funding they do have and collaborate to meet community needs.
'What makes us successful is because of years and years of, really, determination and lived experience and also listening to the community, helping the system to understand ... crossing over boundaries and dividers,' Chung said.
'Sometimes, I move three steps forward, I come back one step, and yet, at the end of the day, I see that we will be OK.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Associated Press
27-06-2025
- Associated Press
EXECUTIVE INTERVIEW: SeaStar CMO And Pediatric Specialist Talk About Promising Therapy To Treat Pediatric AKI
By Meg Flippin, Benzinga DETROIT, MICHIGAN - June 27, 2025 ( NEWMEDIAWIRE ) - Dr. Kevin Chung, Chief Medical Officer at SeaStar Medical Holding Corporation (NASDAQ: ICU) and Dr. Stuart L. Goldstein, MD, from Cincinnati Children's Hospital Medical Center, were recently guests on Benzinga's All-Access. The two were on hand to discuss QUELIMMUNE, SeaStar Medical's humanitarian medical device that was granted U.S. FDA approval to treat pediatric patients with acute kidney injury (AKI) due to sepsis or a septic condition. Dr. Goldstein was the chief investigator for the two studies that led to the FDA approval. Pediatric AKI is a sudden episode of kidney failure that happens within a few hours or days. It can be brought on by several conditions including sepsis, severe trauma and surgery. AKI can cause hyperinflammation, which is the overproduction or overactivity of inflammatory effector cells and other molecules that can be toxic. Damage resulting from hyperinflammation in AKI can progress to other organs, such as the heart or liver and potentially lead to multi-organ dysfunction or even failure that could result in worse outcomes, including increased risk of death. Even after resolution, patients may face complications including chronic kidney disease or end-stage renal disease requiring dialysis. Treating The Untreatable There are about 4,000 cases of pediatric AKI each year in the U.S., Dr. Chung shared, and the mortality rate among those patients is high at 50%. QUELIMMUNE, which was granted approval under a Humanitarian Device Exemption (HDE) by the FDA in February 2024, was developed to treat AKI among children. 'QUELIMMUNE is designed to target the innate immune response. When patients get very sick, it becomes very dysregulated and cells go haywire and trigger something called the cytokine storm,' said Dr. Chung in the interview. 'The QUELIMMUNE device is designed specifically to target the cytokine storm at the source of the storm, and it is associated with really good outcomes, especially in the pediatric population where mortality was cut in half from 50% to 25%.' That reduction in mortality is quite promising given that while there have been medical advances in treating AKI over the years, including targeted medications, nothing has been able to help patients with AKI so severe that it requires dialysis or inflammation so bad that it has increased the chance of death, Dr. Goldstein noted. But QUELIMMUNE proved very effective in trials, surprising even Dr. Goldstein, and that is why it received FDA approval and is being used in hospitals around the country. 'What we saw as we started the initial trial is kids that had a 50% chance of mortality, not only did that go in half, but we saw a dramatic improvement almost in 24 to 48 hours, which was quite shocking to us frankly,' said Dr. Goldstein. What's more, of the patients who survived, they were off dialysis sixty to ninety days later, something unheard of. Typically, 10-30% of pediatric patients who survive an AKI episode require chronic dialysis, Dr. Goldstein shared. 'It's a dramatic improvement that you see almost within the first one to two days. It is nothing I've seen before in clinical medicine in the last quarter century,' he stated further. Looking Beyond Pediatric AKI In addition to treating pediatric AKI, SeaStar is currently engaged in a trial evaluating the safety and efficacy of QUELIMMUNE for treating adult AKI. The study has over 100 patients enrolled, and the company is shooting for a total of 200. Beyond that, Dr. Chung said the idea is to use QUELIMMUNE for any condition in which the innate immune system is disturbed. 'The therapy itself is organ- and disease-agnostic,' said Dr. Chung, noting the company has six Breakthrough Device Designations from the FDA. BDD is designed to encourage speedier development of certain medical devices when there is a reasonable chance of providing a better treatment or diagnosis than the current standard of care. The BDD status is reserved for those diseases that are life-threatening or can cause irreversibly debilitating effects on patients. 'Other disease states are definitely going to be next,' Dr. Chung told Benzinga. Featured image from Shutterstock . This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. This content was originally published on Benzinga. Read further disclosures here.
Yahoo
09-06-2025
- Yahoo
Beacon Therapeutics Appoints Chief Medical Officer
By Karen Roman Biotech company Beacon Therapeutics Holdings Ltd announced the designation of Dr. Daniel Chung as its new Chief Medical Officer. Dr. Chung has three decades of experience in clinical ophthalmology and academic research, and he formerly served as Chief Medical Officer at SparingVision, the company said in a statement. Dr. Chung was also Ophthalmology Therapeutic Area Leader at Spark Therapeutics and participated in the development of Luxturna, the first gene therapy with FDA and EMA approval, it said. 'We are thrilled to welcome Dan to our leadership team,' said Lance Baldo, M.D., Beacon Therapeutics CEO. 'He brings deep clinical and translational expertise in developing gene therapies for retinal diseases and has demonstrated an unwavering commitment to patients and the clinical community supporting blinding diseases.' Contact: Exec Edge Editor@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
28-05-2025
- Yahoo
Jeep's driver sought after DTLA hit-and-run on motorcyclist
The Los Angeles Police Department is asking for the public's help in tracking down a driver who seriously injured a motorcyclist in a crash in downtown Los Angeles and fled without stopping to help. The crash occurred just before 8 p.m. on March 23 at Cesar E. Chavez and Bunker Hill avenues, the Los Angeles Police Department said in a news release. A black Jeep Gladiator, the manufacturer's pickup truck, was headed east on Cesar E. Chavez Avenue and tried to turn left onto Bunker Hill Avenue when it hit an oncoming motorcyclist. Video shared by the LAPD shows the truck slam into the motorcyclist, sending him onto the vehicle's hood and then the ground. The driver then quickly stops, reverses and accelerates away headed west on Chavez Avenue while other motorcyclists film the fleeing truck. The motorcyclist, only identified as a man in his 30s, was taken to a local hospital to be treated for severe injuries. A reward of up to $25,000 is available for information leading to the driver. Anyone with information is asked to call Officer Chung at 213-833-3713. During non-business hours or on weekends, calls should be directed to 1-877-LAPD-24-7 (877-527-3247). To report information anonymously, call Crime Stoppers at 800-222-TIPS (8477) or visit Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.